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Keratinocyte Microvesicles Regulate the Expression of
Multiple Genes in Dermal Fibroblasts
Ping Huang1,2, Jiarui Bi1, Gethin R. Owen1, Weimin Chen2, Anne Rokka3, Leeni Koivisto1, Jyrki Heino4,
Lari Häkkinen1 and Hannu Larjava1
Extracellular vesicles released from cells regulate many normal and pathological conditions. Little is known about
the role of epidermal keratinocyte microvesicles (KC-MVs) in epithelial–stromal interaction that is essential for
wound healing. We investigated, therefore, whether MV-like structures are present in human wounds and
whether they affect wound healing–associated gene expression in dermal ﬁbroblasts. In human wounds, MV-like
vesicles were observed during active epithelial migration and early granulation tissue formation. When KC-MVs
derived from keratinocyte-like cells (HaCaT) were added to ﬁbroblast cultures, expression of 21 genes was
signiﬁcantly regulated (Po0.05) out of 80 genes investigated, including matrix metalloproteinase-1 and -3,
interleukin-6 and -8, and genes associated with transforming growth factor-β signaling. Similar changes were
observed at the protein level. MVs from normal epidermal keratinocytes showed similar response to HaCaT cells.
KC-MVs activated ERK1/2, JNK, Smad, and p38 signaling pathways in ﬁbroblasts with ERK1/2 signaling having the
most prominent role in the MV-induced gene expression changes. KC-MVs stimulated ﬁbroblast migration and
induced ﬁbroblast-mediated endothelial tube formation but did not affect collagen gel contraction by ﬁbroblasts.
The results demonstrate that keratinocyte microvesicles have a strong and a speciﬁc regulatory effect on
ﬁbroblasts that may modulate several aspects of wound healing.
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INTRODUCTION
Cutaneous wound repair consists of numerous overlapping
events, including hemostasis, inﬂammation, proliferation, and
remodeling phases. Throughout the whole repair process,
interaction between different cell types provides coordination
of the individual events, allowing for a temporal and a spatial
control. During the shift from inﬂammation to the granulation
tissue phase, cellular interactions become gradually domi-
nated by the interplay of keratinocytes with ﬁbroblasts. There
is ample evidence that keratinocytes stimulate ﬁbroblasts to
synthesize growth factors, which in turn may stimulate
keratinocyte proliferation in a double paracrine manner
(Werner, Krieg and Smola, 2007). Epidermal keratinocytes
can interact with dermal ﬁbroblasts either via soluble
mediators or via secreted vesicles that can carry signaling
molecules to transfer information between the two cell types.
It is not well known, however, how keratinocyte-derived
extracellular vesicles regulate ﬁbroblast function.
Recently, extracellular vesicles (a common term for both
microvesicles (MVs) Ø100–1,000 nm and exosomes Ø30–
100 nm) have become an extensive ﬁeld of study and are
considered an important intercellular communication system
that regulates many normal and pathological processes (Rak,
2010; Kahlert and Kalluri, 2013). Exosomes are derived from
endosomes, whereas MVs are shed from the cell membrane.
These vesicle types may have both overlapping and distinct
biological function. MVs can originate from many cell types
in vivo and in vitro, including epithelial, ﬁbroblast,
hematopoetic, immune, placental, and tumor cells (VanWijk
et al., 2003; Wieckowski and Whiteside, 2006; Valenti et al.,
2007; Pap et al., 2008). MVs represent “mini-cells” containing
a soluble core surrounded by a lipid bilayer. The core
contains nucleic acids (DNA, messenger RNA (mRNA), and
microRNA) and proteins that together with the membrane
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lipids and proteins constitute the cargo of the MVs (Rak,
2010; Kahlert and Kalluri, 2013). They can travel and reach
distant targets while the cargo is being kept protected
from degradation by the surrounding lipid membrane
(El-Hefnawy et al., 2004; Rak, 2010). MVs facilitate cell–cell
communication via receptor-mediated delivery and transfer of
a variety of signaling molecules to the target cells, thus
participating in, for example, the regulation of cytokine and
matrix metalloproteinase release from their target cells and
angiogenesis (Losche et al., 2004; Camussi et al., 2010).
In the present study, we elucidated the morphology and
composition of KC-MVs and studied their effect on the
expression of wound healing–associated genes and cell
behavior in dermal ﬁbroblasts. The ﬁndings show a potential
role for KC-MVs in the interactions between keratinocytes and
ﬁbroblasts during wound healing.
RESULTS
Vesicle-like structures in human wounds
We analyzed 3-day-old human mucosal wounds showing
active re-epithelialization for the presence of vesicular
structures. Three different zones with various stages of base-
ment membrane formation were investigated (Figure 1a–c). In
all the zones, vesicular structures resembling MVs were
observed in the vicinity of keratinocytes.
Keratinocytes release MVs that bind to ﬁbroblasts
To investigate the possible regulation of ﬁbroblast functions
by KC-MVs, we isolated them from keratinocyte serum-free-
conditioned medium by centrifugation at 25,000g and
analyzed them by scanning transmission electron micro-
scopy. In 48 hours, keratinocytes produced about 0.5 μg MVs
(protein content) per million cells (data not shown). The mean
vesicle size was 0.3 μm (Figure 1d) that is typical for MVs (Al-
Nedawi, Meehan and Rak, 2009). To ﬁnd out whether these
MVs can bind to ﬁbroblasts, ﬂuorescently labeled KC-MVs
were added to the ﬁbroblast cultures. After 3 hours, numerous
MVs were found attached to the target cells (Figure 1e).
Next, we analyzed the protein content of the MVs by
tandem mass spectrometry (MS/MS). In total, 1,204 proteins
were present in each of the three replicate samples when two
peptides and Po0.05 signiﬁcance level were used as the
threshold. Proteins were then ranked by the gene ontology
tool in The Database for Annotation, Visualization, and
Integrated Discovery (DAVID) using default settings. Eleven
categories of proteins were identiﬁed using a cut-off level of
Po0.05 (Modiﬁed Fisher’s exact test). Categories representing
proteins in cytosol, ribosomes, RNA-binding, and intracellular
organelle lumen were enriched in the KC-MVs (Figure 1g,
Supplementary Table S1 online).
KC-MVs regulate expression of genes important for wound
healing
To ﬁnd out whether KC-MVs regulate the expression of
wound healing–related genes in dermal ﬁbroblasts, we treated
these cells with different concentrations of MVs (0–24 μg
protein ml− 1) for 24 hours, followed by quantitative real-time
reverse transcription PCR (RT–qPCR). Treatment with the MVs
did not change the total RNA content in ﬁbroblasts (not
shown). Collectively, among the 80 genes studied, 21 genes
(26%) showed signiﬁcantly altered expression (Po0.05). The
expression of 14 genes was dose-dependently upregulated,
whereas 7 genes were downregulated (Figure 2).
First, we tested the mRNA expression of the major ﬁbroblast
matrix proteins that are highly regulated during wound
healing (24 genes in total). Six of these (25%) were speciﬁ-
cally regulated by the KC-MVs. The expression of connective
tissue growth factor (CCN2/CTGF), emilin-3, lumican, and
thrombospondin-1 (THBS1) mRNA was dose-dependently
upregulated by 2- to 3-fold by the KC-MVs, whereas
nephroblastoma overexpressed (CCN3/NOV) and tenascin-X
(TNX) genes were signiﬁcantly downregulated (Figure 2a).
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Figure 1. Characterization of keratinocyte-derived MVs. (a–c) Vesicle-like
structures are present in human 3-day-old wounds during different stages of
basement membrane (BM, arrows) formation (a, no BM; b, BM at early stage;
c, fully established BM). Arrowheads point the vesicular structures present in
keratinocytes (KC), the nearby ﬁbrin clot (FC), and connective tissue (CT).
Bar=1 μm. (d) STEM image of KC-MVs. Bar = 5 μm. (e and f) Fibroblasts were
treated with ﬂuorescently labeled (Vybrant DiI) KC-MVs for 3 hours (e); control
cells not treated with MVs (f). (g) Gene ontologies (DAVID) associated with the
1,204 proteins found in the MS/MS analysis of KC-MVs (cut-off level of
Po0.05; Modiﬁed Fisher’s exact test). MS/MS, tandem mass spectrometry;
MV, microvesicle; STEM, scanning transmission electron microscopy.
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Matrix remodeling is an important part of granulation tissue
formation (Page-McCaw, Ewald and Werb, 2007; Toriseva and
Kahari, 2009). Therefore, we investigated the effect of KC-MVs
on the expression of nine matrix metalloproteinase (MMP) and
four tissue inhibitors of metalloproteinase (TIMP) genes
(Figure 2b). Fibroblasts expressed detectable levels of only
MMP1, MMP2, and MMP3, of which MMP1 and MMP3 were
signiﬁcantly and dose-dependently regulated by KC-MVs (up to
4.5-fold; Figure 2b). The expression of TIMP3 and TIMP4 was,
however, dose-dependently downregulated (Figure 2b).
Transforming growth factor-β (TGF-β) signaling regulates a
number of key events in wound healing (Li, Zhang and
Kirsner, 2003; Werner and Grose, 2003). Consequently, we
investigated the effect of KC-MVs on the expression of 14
ﬁbroblast genes involved in TGF-β signaling. Only four genes
(29%) were regulated by KC-MVs (Figure 2c). Among TGF-β
isoforms, the expression of TGFB2 was dose-dependently
downregulated (33%, Figure 2c), whereas TGFB1 and TGFB3
were not regulated (not shown). Of the TGF-β receptors, the
expression of TGFBRII was signiﬁcantly upregulated (1.5-fold,
Figure 2c), whereas the expression of TGFBRI and TGFBRIII
was not affected by the KC-MVs (not shown). We then
examined how the KC-MVs regulate the expression of
transcription factors involved in TGF-β signaling and their
inhibitors. Transcription factor early growth response proteins
(Egr-1, -2, and -3) mediate TGF-β signaling and collagen
production in ﬁbroblasts (Bhattacharyya et al., 2011). The
expression of Egr genes was not, however, regulated by the
KC-MVs in ﬁbroblasts. In contrast, the expression of the Egr-1
binding protein (NAB1) mRNA was dose-dependently
increased (2.4-fold, Figure 2c) by the KC-MVs. Similarly, the
gene expression of another TGF-β signaling inhibitor,
collagen triple helix repeat containing-1 (CTHRC1), was
upregulated (Figure 2c). However, the gene expression of
Smad-7 (an inhibitor of Smad signaling) was not changed
(not shown).
To investigate the effect of KC-MVs on ﬁbroblast differ-
entiation to myoﬁbroblasts, we analyzed the expression of
eight genes associated with ﬁbroblast differentiation and cell
contractility. Of these, only the expression of α-smooth
muscle actin (α-SMA; a myoﬁbroblast signature gene) and
cadherin-2 (a cell adhesion protein) genes was found to be
downregulated by the KC-MVs (26 and 36%, respectively;
Figure 2d).
Regulation of blood vessel formation and regression is
crucial for wound healing (Johnson and Wilgus, 2014).
Therefore, we investigated the effect of KC-MVs on the gene
expression of vascular endothelial growth factor-A (VEGF-A),
ﬁbroblast growth factor-2 (FGF-2), and C-X-C motif chemo-
kine ligand 12 (CXCL12) in dermal ﬁbroblasts. Only expres-
sion of FGF2 was dose-dependently upregulated by the KC-
MVs (1.7-fold, Figure 2e).
Basement membrane formation is critical for establishing
the epithelial barrier function at the later stages of wound
healing. Keratinocytes and ﬁbroblasts collectively contribute
proteins to the basement membrane zone (Varkey, Ding and
Tredget, 2014). The gene expression of basement membrane
components laminin-111 and collagen IV was not altered by
KC-MVs, whereas that of laminin-332 and collagen VII was
upregulated by about 2-fold (Figure 2e).
Cytokines and chemokines are important regulators of
wound healing (Barrientos et al., 2008). Among nine genes
investigated (Supplementary data online), only IL8 and IL6
were dose-dependently regulated by the KC-MVs (10- to
14-fold increase, respectively; Figure 2f).
Next, we tested whether KC-MVs derived from normal
adult and newborn epidermal keratinocytes also regulate
MMP-1 and IL-6 genes, which were highly regulated by
HaCaT-derived MVs in ﬁbroblasts. Normal keratinocytes
produced lower amounts of MVs compared with HaCaTs
(not shown). Regardless, the mRNA expression of both
MMP-1 and IL-6 was similarly upregulated by MVs from all
three cell lines, suggesting that this regulation is not limited to
HaCaT cells (Figure 3a).
KC-MVs regulate MMP-1, MMP-3, cadherin-2, THBS1, and IL-6
protein production in ﬁbroblasts
Having demonstrated that KC-MVs regulate the expression
of multiple ﬁbroblast genes, we assessed whether these
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Figure 2. The effect of KC-MVs on the expression of wound healing–related
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TGF, transforming growth factor.
P Huang et al.
Keratinocyte Microvesicles and Fibroblasts
www.jidonline.org 3053
differences were also present in a set of the respective
proteins. The accumulation of lumican, MMP-1, and MMP-3
was dose-dependently increased by KC-MVs in the ﬁbroblast
medium, reﬂecting the changes at the mRNA level (Figure 3b
and c). The protein level of cell layer–associated cadherin-2
was downregulated, whereas THBS1 was signiﬁcantly upre-
gulated by KC-MVs (Figure 3b and c), again reﬂecting the
regulation at the mRNA level. Similarly, medium IL-6 levels
were elevated (Figure 3d). None of these proteins were
detected when KC-MVs alone were analyzed, indicating that
all the proteins quantiﬁed were produced by the ﬁbroblasts
(not shown).
MAPK and Smad pathways are activated by KC-MVs in
ﬁbroblasts
To investigate which signaling pathways regulate the KC-MV-
induced altered gene expression proﬁle, we assessed the
activation of the main signaling pathways in ﬁbroblasts,
namely TGF-β/Smad and mitogen-activated protein kinase
(MAPK) pathways, including p38, extracellular signal–
regulated kinase-1/2 (ERK1/2), and c-Jun N-terminal kinase
(JNK). Interestingly, all the four pathways were activated
in ﬁbroblasts by the KC-MVs, albeit with different peak
time points (Figure 4a). Smad3 and p38 showed peak
activation at 30–60 minutes, whereas ERK1/2 and JNK were
maximally activated in 15 minutes (Figure 4a). Next, we
tested the effect of various concentrations of KC-MVs on
these pathways at the peak response time point. Consistent
with the previous results, all signaling pathways were
dose-dependently activated (Figure 4b and c). Next, we
explored which pathways participated in the regulation
of the gene expression proﬁles using chemical inhibitors.
The KC-MV-induced expression of CCN2 mRNA in ﬁbro-
blasts was abolished with all inhibitors tested (Figure 5a),
suggesting that these pathways are collaboratively involved.
MV-regulated expression of CCN3 mRNA, however, was
partially normalized only with the Smad pathway inhibitor
SB431542 (Figure 5a). Inhibitors for the ERK1/2 (PD184352)
and p38 (SB203580) pathways partially normalized the
KC-MV-induced expression of emilin-3 gene (Figure 5a),
whereas elevated expression of THBS1 gene was normalized
060 HEKa 2 μg
NHEK 2 μg
HaCat 2 μg
HaCat 30 μg
0 μg ml–1
8 μg ml–1
3 μg ml–1
24 μg ml–1
***
***
***
***
***
***
***
*
40
R
el
at
iv
e 
m
R
N
A 
ex
pr
es
sio
n
R
el
at
iv
e 
pr
ot
ei
n 
am
ou
nt
20
MM
P1 IL-
6
0
*** *** *
*
**
*
2
1.5
1
m
 lu
mi
ca
n
c c
ad
he
rin
-2
c T
HB
S1
m
 M
MP
-1
m
 M
MP
-3
0.5
0
2483
m lumican
β-Tubulin
c cadherin-2
c THBS1
β-Tubulin
c  MMP-1
m MMP-1
c  MMP-3
m MMP-3
β-Actin
(μg protein ml–1)MVsba
c d
Control MVs
0
50
100
150
200
250
IL
-6
 c
on
ce
nt
ra
tio
n 
(pg
 m
l–1
)
Figure 3. The effect of KC-MVs on wound healing–related mRNA and protein
expression in ﬁbroblasts. (a) The effect of KC-MVs (2 or 30 μg protein ml− 1)
from normal adult (HEKa) and newborn epidermal keratinocytes (NHEK) on
the expression of ﬁbroblast MMP-1 and IL-6 genes as compared with HaCaT
MVs. (b) The protein abundance of selected proteins (lumican, cadherin-2,
THBS1, MMP-1, and MMP-3) measured in the cell layer (c) or the conditioned
medium (m) of KC-MV-treated ﬁbroblasts by western blotting, using either
β-tubulin or β-actin as a loading control. (c) The protein levels quantiﬁed by
ImageJ. (d) IL-6 protein in cell culture medium measured by ELISA. Results
show mean± SEM from triplicate experiments (*Po0.05, **Po0.01,
***Po0.001; one-way analysis of variance followed by least signiﬁcant
difference). KC-MV, keratinocyte microvesicle; MMP, matrix
metalloproteinase.
0
c
ba (min)
1206030
p-Smad3
Smad3
β-Actin
p-p38
p38
β-Tubulin
(μg protein ml–1)MVs
p-Smad3
Smad3
β-Actin
p-p38
p38
β-Tubulin
80 3 24
p-ERK1/2
ERK1/2
β-Tubulin
p-JNK
JNK
p-Smad3/Smad3
p-p38/p38
p-ERK/ERK
p-JNK/JNK
MVs protein (μg ml–1)
Ph
os
ph
or
yla
te
d 
/ t
ot
al
β-Tubulin
0 603015
3
2
1
0
0 10 20 30
**
**
*
***
p-ERK1/2
ERK1/2
β-Tubulin
p-JNK
JNK
β-Tubulin
Figure 4. Activation of cell signaling pathways in ﬁbroblasts by KC-MVs.
(a) The time points for peak activation of ﬁbroblast MAPK and TGF-β/Smad
signaling pathways were determined using a single dose of KC-MVs (24 μg
protein ml−1) by western blotting. Subsequently, the effect of different
concentrations of KC-MVs on ﬁbroblast cell signaling pathways was tested
using the maximum response time point (b). (c) The experiments were
performed in triplicates, and the results quantiﬁed using ImageJ. The results
show mean± SEM (*Po0.05, **Po0.01, ***Po0.001; one-way analysis of
variance followed by least signiﬁcant difference). KC-MV, keratinocyte
microvesicle; MAPK, mitogen-activated protein kinase; TGF, transforming
growth factor.
P Huang et al.
Keratinocyte Microvesicles and Fibroblasts
3054 Journal of Investigative Dermatology (2015), Volume 135
by both SB203580 and JNK inhibitor SP600125 (Figure 5a).
Inhibition of ERK1/2 activation reduced the MV-induced
expression of MMP1, MMP3, IL6, and IL8 signiﬁcantly
(Figure 5b and d), suggesting that ERK signaling was
responsible for the large induction of these genes. As
expected, KC-MV-induced medium accumulation of MMP-1
and MMP-3 was also signiﬁcantly reduced by ERK1/2
inhibition (Figure 5e and f).
KC-MVs regulate ﬁbroblast migration and ﬁbroblast-mediated
in vitro angiogenesis
To ﬁnd out how the altered gene expression translates to
changes in ﬁbroblast functions, we conducted assays that
measure ﬁbroblast migration, angiogenesis, and collagen gel
contraction. KC-MVs stimulated ﬁbroblasts migration in a
scratch assay but did not regulate collagen gel contraction
(Figure 6a–d). Interestingly, conditioned medium from KC-
MV-treated ﬁbroblasts signiﬁcantly promoted angiogenesis by
endothelial cells in vitro (Figure 6e–g).
DISCUSSION
In this study, we have shown that keratinocytes can transfer
information to ﬁbroblasts in the form of MVs that can then
regulate ﬁbroblast gene and protein expression, leading
to increased ﬁbroblast migration and ﬁbroblast-mediated
angiogenesis. The double paracrine interaction between
keratinocytes and ﬁbroblasts has been well investigated
(Maas-Szabowski et al., 2003; Werner et al., 2007). Little is
known, however, how keratinocyte-derived MVs regulate
ﬁbroblast function. MVs are released from many cell types
during wound healing (Lai et al., 2014). Unsurprisingly, we
identiﬁed vesicles in the electron micrographs from human
wounds. Because of close proximity to wound keratinocytes,
the MV-like structures may have originated from these
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cells. Cultured keratinocyte-like HaCaT cells spontaneously
released MVs that caused speciﬁc changes in the expression
of wound healing–related genes in ﬁbroblasts. More than a
third of the regulated genes appeared to be involved in TGF-β
signaling. CCN2, a downstream target of TGF-β signaling
that promotes ﬁbroblast matrix production, migration, and
expression of pro-angiogenic genes (Kennedy et al., 2007;
Lau, 2012; Alfaro et al., 2013), was upregulated by the
KC-MVs. In contrast, the mRNA expression of CCN3 was
downregulated. Interestingly, CCN3 has been recently
demonstrated to limit CCN2-induced matrix production
independent of TGF-β signaling (Riser et al., 2009, 2014).
In agreement with the gene expression changes involving
TGF-β signaling molecules, Smad signaling was increased in
KC-MV-treated ﬁbroblasts. To initiate TGF-β signaling, latent
TGF-β needs to be activated. THBS1 that was also upregu-
lated by the KC-MVs could have such a role, as it is one of the
major physiologic activators of latent TGF-β (Schultz-Cherry
and Murphy-Ullrich, 1993; Crawford et al., 1998). The
increased TGF-β signaling and CCN2 gene expression did
not, however, upregulate collagen I or III gene expression,
although the expression of type VII collagen and laminin-332
genes was increased. It is likely, therefore, that other factors
capable of modulating TGF-β signaling are involved.
In our gene proﬁling, three such molecules were upregulated
by KC-MVs, namely emilin-3, CTHRC1, and NAB1. Emilin-3
binds pro-TGF-β1 and prevents its proteolytic activation
(Schiavinato et al., 2012). On the other hand, nuclear
transcriptional co-repressor protein NAB1 can bind and block
functions of Egr-1 required for TGF-β-mediated ﬁbrotic
responses (Thiel et al., 2000; Bhattacharyya et al., 2013).
Finally, CTHRC1 has been shown to inhibit TGF-β signaling
in ﬁbroblasts (LeClair et al., 2007; Li et al., 2011).
It appears, therefore, that KC-MVs induce expression of
both positive and negative modulators of the TGF-β signal-
ing pathway, resulting in selective regulation of matrix
protein genes.
Inhibitor experiments indicated that ERK1/2 signaling was
involved in MV-induced gene expression changes in ﬁbro-
blasts. For instance, mRNA and protein expression of MMP-1
and MMP-3 was strongly induced via ERK1/2 signaling.
Involvement of the ERK1/2 pathway in the activation of
MMP1 promoter and induction of MMP-1 production in
ﬁbroblasts is well documented (Westermarck et al., 2001).
ERK1/2 can be activated by a variety of signals, and future
studies should address the speciﬁc cargo in the KC-MVs that is
responsible for this activation. In the context of wound
healing, it is possible that KC-MV-induced MMP production
in ﬁbroblasts inﬂuences both matrix remodeling and inﬂam-
mation, thus allowing keratinocytes to participate in tissue
remodeling. Both MMP-1 and MMP-3 may also regulate
chemokine activity, either positively or negatively (Gill and
Parks, 2008). Expression of TIMP3 and -4 genes was also
downregulated by KC-MVs, shifting the balance toward
higher MMP activity. Keratinocyte-derived exosomes contain
stratiﬁn (14-3-3σ) that can stimulate MMP-1 expression in
ﬁbroblasts (Chavez-Munoz et al., 2009; Medina and Ghahary,
2010). Because stratiﬁn was also present in our proteomics
screen of KC-MVs, we produced stratiﬁn-deﬁcient KC-MVs by
RNA interference. Expression of MMP-1 and -3 by ﬁbroblasts
was not dependent on the presence of stratiﬁn in KC-MVs
(PH, unpublished data), suggesting a differential mechanism
of MMP regulation between exosomes and MVs. Increased
MMP expression is linked to tissue contraction in vivo and
in vitro (Koskinen et al., 2002; Harrison et al., 2006). We did
not observe any changes in ﬁbroblast-mediated collagen gel
contraction by KC-MVs, suggesting that elevated MMP
expression was required for other functions (Larjava et al.,
2011). As the role of MMPs in ﬁbroblast migration is well
recognized (Ghersi et al., 2002; Fujiwara et al., 2005), one of
these functions could be the increased MV-induced ﬁbroblast
migration we observed in our study. Additional promoters of
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Figure 6. Regulation of ﬁbroblast migration, collagen gel contraction,
and ﬁbroblast-mediated angiogenesis by keratinocyte microvesicles
(KC-MVs). (a) Conﬂuent ﬁbroblast cultures were scratch wounded and
exposed to KC-MVs (6 μg protein ml−1) for 10 hours. (b) The remaining wound
area quantiﬁed by ImageJ from triplicate experiments. (c) Collagen gel
contraction by ﬁbroblasts with or without KC-MVs (24 μg protein ml−1).
(d) Gel contraction quantiﬁed from triplicate experiments using ImageJ after
48 hours. (e) Endothelial cells seeded on basement membrane matrix treated
with concentrated (5× ) conditioned medium from KC-MV–treated (24 μg
protein ml−1) ﬁbroblasts. Angiogenesis was quantiﬁed as (f) “branches per
intersection” and (g) “lengths of branches” in randomly selected images from
the culture plates. The results show mean± SEM from triplicate experiments
(*Po0.05, **Po0.01, Student's t-test).
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ﬁbroblast migration induced by KC-MVs are CCN2 and
CTHRC1 (Pyagay et al., 2005; Kennedy et al., 2007).
In wounds, ﬁbroblasts undergo differentiation to contractile
α-SMA-expressing myoﬁbroblasts (Hinz et al., 2004). KC-MVs
signiﬁcantly reduced α-SMA mRNA expression but also
lowered cadherin-2 gene expression. During ﬁbroblast
differentiation mediated by the TGF-β pathway, α-SMA is
induced and cadherin-2 expression is switched to cadherin-
11 (Hinz et al., 2004). Thus, KC-MVs appear to have
dual and contradictory effects in the regulation of ﬁbro-
blast phenotype by priming them toward myoﬁbroblasts
(cadherin-2 reduction) but blocking the full differentiation
(reduced α-SMA).
Expression of IL-6 and 1L-8 was signiﬁcantly induced by
KC-MVs. IL-6 contributes to wound healing by promoting
keratinocyte migration, macrophage inﬁltration, angiogenesis,
and wound contraction (McFarland-Mancini et al., 2010).
IL-8 is chemotactic to neutrophils and macrophages but
also promotes angiogenesis (Martins-Green et al., 2013). In
addition to these cytokines, the expression of angiogenic
FGF-2 (Presta et al., 2009) and CCN2 (Kennedy et al., 2007)
was signiﬁcantly stimulated by KC-MVs. Reduced TIMP3
expression by KC-MVs could also promote blood vessel
formation, as TIMP3 is a strong inhibitor of angiogenesis
(Qi and Anand-Apte, 2015). A combined net effect of these
factors is likely increased endothelial tube formation.
Interestingly, KC-MVs alone had no effect on tube formation,
suggesting that keratinocytes can use ﬁbroblasts as mediators
of angiogenic stimulus to endothelial cells. This may be a cell
type–speciﬁc event, as vesicles from adipose mesenchymal
stem cells can directly support angiogenic activity (Lopatina
et al., 2014).
Most data for this paper were produced using epidermal
keratinocyte–like cells (HaCaT). However, the results with
normal keratinocyte-derived MVs were consistent with
HaCaT cells, suggesting that the ﬁbroblast response to KC-
MVs is a distinct form of keratinocyte–ﬁbroblast interaction.
We have observed that keratinocytes respond differently from
ﬁbroblasts when they are exposed to KC-MVs (JB, unpub-
lished data), supporting the view that MV effects are cell-type
speciﬁc. We cannot rule out, however, the possibility that
KC-MV effects on ﬁbroblast activity and function may vary
depending on the keratinocyte or ﬁbroblast differentiation
state and the stage of wound healing.
In conclusion, this study shows that KC-MVs have
multiple effects on ﬁbroblast gene and protein expression that
translate to increased ﬁbroblast migration and enhanced
ﬁbroblast-mediated angiogenesis. Vesicle-mediated transfer
of information between different wound cell types may
make a signiﬁcant contribution to wound healing. In addi-
tion, defective MV secretion/function may contribute to
aberrant wound healing and chronic wounds that fail to
re-epithelialize.
MATERIALS AND METHODS
Wound specimens and electron microscopy
Wounds were created on palatal mucosa on ﬁve volunteers who
had provided written informed consent (Larjava et al., 1993). Seven
3-day-old wound specimens were processed for TEM, and the
micrographs examined for the presence of potential extracellular
vesicles. The study was approved by the Ethical Committee of the
University of Turku, Finland.
Cell culture and collection of microvesicles from the culture
medium
The immortalized human epidermal keratinocyte–like cell line
HaCaT, normal human adult and newborn epidermal keratino-
cytes, and normal human dermal ﬁbroblasts were used for this
study.
For MV collection, conﬂuent keratinocytes were cultured in a
serum-free medium for 48 hours. MVs were pelleted by centrifuga-
tions at 25,000g for 30 minutes at +4 °C. (see Supplementary
Materials and Methods online for the cell culture and MV collection
details).
Treatment of ﬁbroblasts with MVs
Fibroblasts were treated with different concentrations of KC-MVs
for 24 hours (total RNA isolation) or 48 hours (protein isolation)
in a serum-free medium. Expression of wound healing–associated
genes and proteins was analyzed using RT–qPCR and western
blotting, respectively (Mah et al., 2014). PCR primers and antibodies
are listed in Supplementary Table S2 and S3 online, respectively. The
protein accumulation of IL-6 in conditioned medium was quantiﬁed
using the human IL-6 ELISA kit (Boster Biologics, Pleasanton, CA,
USA). To assess activation of cellular signaling pathways, the
ﬁbroblasts were pre-incubated in a serum-free medium for 2 hours
and then treated with or without KC-MVs. The activation of
MAPKs (ERK1/2, JNK, and p38) and Smad3 signaling was analyzed
by western blotting. In a set of experiments, the above pathways were
blocked by corresponding chemical inhibitors (Supplementary Table
S4 online).
Mass spectrometry
The protein content of MVs from triplicate specimens was analyzed
using tandem mass spectrometry (MS/MS; see Supplementary
Materials and Methods online).
Scanning transmission electron microscopy
MV morphology assessed by scanning transmission electron micro-
scopy (see Supplementary Materials and Methods online).
Detection of MVs entering ﬁbroblasts
Fibroblast monolayers seeded on coverslips were treated with
MVs pre-labeled with Vybrant DiI (Invitrogen, Eugene, OR) for 3,
8, and 24 hours (see Supplementary Materials and Methods online).
Functional assays of ﬁbroblasts
Effect of MVs on migration and collagen gel contraction by
ﬁbroblasts, and angiogenesis by endothelial cells, was assessed as
described in the Supplementary Materials and Methods online.
Statistical analysis
All the data are presented as mean± SEM from repeated experiments
(n⩾ 3). Either Student’s t-test or analysis of variance followed by least
signiﬁcant difference post hoc test was used for statistical analysis.
Po0.05 was considered statistically signiﬁcant. Values obtained
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from the RT–qPCR by the comparative Ct-method were Log2-
transformed for statistical testing.
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